GAD and Cormorbidity: Impact on Patient Health

Generalized Anxiety Disorder (GAD) is common, chronic, and associated with substantial impairment in function and quality of life. GAD commonly occurs comorbid with mood disorders and anxiety disorders. GAD comorbidity has been clearly linked to additive worsening of outcomes and function in both Major Depressive Disorder and in Bipolar Disorder. This presentation will provide an update on current understandings about the incidence and nature of GAD and comorbid disorders, and their impact on patient health. During this webinar attendees will: 1) Understand the overlap of Generalized Anxiety Disorder (GAD) with mood disorders 2) Understand the impact of GAD comorbidity on severity of illness including suicidality, quality of life and functioning in individuals with GAD 3) Learn about the need to address GAD and its comorbidities to optimally improve patient health Naomi Michele Simon, M.D., M.Sc. Dr. Naomi M. Simon is Associate Director of the Center for Anxiety and Traumatic Stress Disorders and Director of the recently established Complicated Grief Program at Massachusetts General Hospital, and is Associate Professor of Psychiatry, Harvard Medical School. Blackwell Futura Media Services designates this educational activity for 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. DETAILS at: http://bit.ly/ADAA_CME5

Presenting

Dr. Naomi M. Simon, Associate Director of the Center for Anxiety and Traumatic Stress Disorders

Channel

ADAA Webinar Series

Date

Nov 09 2010

Duration

01:05

Tags

GAD, and, Cormorbidity, Dr., Naomi, M., Simon, ADAA